NHRA MDRMDR Guideline — Authorized Representative Registration, Ver 7.4
MDR Guideline — Authorized Representative Registration, Ver 7.4 is the official NHRA identifier for “Medical Device Authorized Representative Registration Guideline, Version 7.4”. MDR Guideline — Authorized Representative Registration, Ver 7.4 is the official identifier NHRA uses for this instrument.
- Instrument
- MDR
- Full name
- MDR Guideline — Authorized Representative Registration, Ver 7.4
- Category
- Registration
- Authority source
- English
- Readable HTML
- 0 articles · 1 language version
- Published
- —
- Effective
- —
Open a language version
Each version has stable article anchors for direct citations and highlighting. The readable text is generated from an authority source and does not replace the legally controlling publication.
Medical Device Authorized Representative Registration Guideline, Version 7.4
Medical Device Authorized Representative Registration Guideline, Version 7.4 (June 2023) — how a foreign manufacturer's authorized representative is registered and what the role carries. Nine numbered sections: the introduction, the general rules, the submission of registration, the requirements, the inspection process and its elements, certificate renewal and variation, the registered authorized representative classification, the commercial registration certificate and the annex. This is the row a foreign manufacturer needs, because the authorized representative is the legal person through whom the Bahraini registration is held. The document states no publication date of its own.
MDR Guideline — Authorized Representative Registration, Ver 7.4 is the official identifier NHRA uses for this instrument. Always confirm the current consolidated text and transition provisions with the official source before filing.